Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Advanced Cell Diagnostics (ACD) logo — RNA expression like you've never seen before

Advanced Cell Diagnostics (ACD)

RNA expression like you've never seen before

Founded 2006 United States Newark, United States 143 employees Series C Biotechnology, Health Care +1

General Information

Company Name Advanced Cell Diagnostics (ACD)
Founded Year 2006
Location United States Newark, United States
Employees 143
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Advanced Cell Diagnostics (ACD). To contact Advanced Cell Diagnostics (ACD), visit acdbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Advanced Cell Diagnostics (ACD) compare?

A PDF of Advanced Cell Diagnostics (ACD) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Advanced Cell Diagnostics (ACD) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Advanced Cell Diagnostics (ACD)

Advanced Cell Diagnostics (ACD) is a leading player in the biotechnology, healthcare, and pharmaceutical industries. The company, acquired by Bio-Techne, has made significant strides in personalized medicine and molecular pathology. Founded in 2006 and headquartered in Silicon Valley, ACD is spearheading the development of cell- and tissue-based research and diagnostic tests. Its breakthrough RNAscope™ technology, with over 10,000 publications, has positioned the company at the forefront of RNA analysis. The proprietary platform, capable of detecting and quantifying single molecules of RNA in situ, has paved the way for personalized medicine and advancement in drug development. With product lines such as RNAscope and BaseScope™, as well as a Professional Assay Services business, ACD offers a comprehensive catalog including >50,000 target probes and assay kits for single, duplex, and multiplex RNA analysis. Although ACD has made remarkable progress, the details of its last investment and investors are currently undisclosed. For more information, visit www.acdbio.com.

No funding data available for Advanced Cell Diagnostics (ACD) yet.

FAQ About Advanced Cell Diagnostics (ACD)

RNA expression like you've never seen before
Advanced Cell Diagnostics (ACD) was founded in 2006.
Advanced Cell Diagnostics (ACD) is headquartered in Newark, United States.
Advanced Cell Diagnostics (ACD) operates in Biotechnology, Health Care and Pharmaceutical.
Advanced Cell Diagnostics (ACD) has approximately 143 employees.

We're actively collecting intelligence on Advanced Cell Diagnostics (ACD).

Source: BounceWatch company record for Advanced Cell Diagnostics (ACD), https://bouncewatch.com/company/advanced-cell-diagnostics-acd, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout